Found 221 matching trials
Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma PHASE1 This trial is divided into two parts, a dose-escalation study (phase 1) and...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer PHASE1 RATIONALE: Drugs used in chemotherapy, such as hydroxychloroquine, carbopla...
Show More Location
Cancer Institute of New Jersey at Hamilton
Learn More & Join Trial
A Study of T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expressing Tumors PHASE2 This is an open-label, multicenter, Phase II study to evaluate the efficacy...
Show More Status
Active Not Recruiting
Learn More & Join Trial
LEAC-102 for Advanced Colorectal Cancer PHASE1 A Phase I/IIa Dose-Escalation Study Evaluating the Safety, Tolerability and...
Show More Location
Multiple Locations
Learn More & Join Trial
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1,Chemotherapy and Target Therapy for Metastatic Colorectal Cancer PHASE2 To improve the survival in patients with microsatellite stable metastatic c...
Show More Learn More & Join Trial
Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor PHASE2 The purpose of this research study is to see how useful it is to look at bi...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade PHASE2 This study will evaluate efficacy and safety of anti-PD-1/PD-L1 antibodies ...
Show More Location
EuroCityClinic LLC
Learn More & Join Trial
Combination Therapy for BRAF-V600E Metastatic CRCm PHASE2 The BRAVE is a phase II clinical trial aimed at evaluating the efficacy of ...
Show More Location
Vall d'Hebron Hospital
Learn More & Join Trial
An Open-label Study of SG1827 Combined With Anti-PD-1/PD-L1 Antibody and Bevacizumab in Patients With Advanced Solid Tumors PHASE1 This multicenter, open-label Phase Ib/II study with dose escalation and exp...
Show More Location
Chongqing University Cancer Hospital
Learn More & Join Trial
Phase Ib and Phase II Studies of MK-3475 in Combination + for Renal Cell Carcinoma: PHASE1 This is an open label, multi-institutional, single arm study of dose escala...
Show More Location
Northwestern University, Robert H. Lurie Cancer Center
Learn More & Join Trial